Targeting Kif11 to Treat Glioblastoma Invasion and Proliferation
靶向 Kif11 治疗胶质母细胞瘤侵袭和增殖
基本信息
- 批准号:10083766
- 负责人:
- 金额:$ 56.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-01 至 2021-12-31
- 项目状态:已结题
- 来源:
- 关键词:ABCB1 geneABCG2 geneAddressBindingBrainBrain NeoplasmsCRISPR/Cas technologyCell TransplantationCellsCentrosomeChronicClinicalConvectionDataDiseaseDrug Delivery SystemsDrug ExposureDrug resistanceEnzymesEpidermal Growth Factor ReceptorEpidermal Growth Factor Receptor Tyrosine Kinase InhibitorFamilyGene Expression ProfileGenerationsGenesGenetic TranscriptionGlioblastomaGliomaImpairmentInvadedKinesinMeasuresMediatingMethodsMicrotubulesMitosisMitoticMitotic spindleMolecular MotorsMusMutationNeuraxisPatientsPharmaceutical PreparationsPhenotypePlayPoint MutationPre-Clinical ModelProliferatingPumpRelapseResistanceResistance developmentRoleTestingTherapeuticTranscription AlterationTumor Cell InvasionUp-Regulationbasecancer cellcell killingcell motilitydrug developmentdrug sensitivityeffective therapyefficacy evaluationefflux pumpexperienceexperimental studyimprovedimproved outcomeinhibitor/antagonistmalignant phenotypemouse modelneoplastic cellnovel therapeuticsoverexpressionprematurepreventresponsesingle-cell RNA sequencingtargeted treatmenttranscriptomicstranslational studytumor
项目摘要
PROJECT DESCRIPTION
The ability of glioblastomas to proliferate in an uncontrollable manner and disperse widely within normal brain
define the malignant phenotype and make this disease uniformly lethal. We have identified an enzyme that is
essential for both glioblastoma invasion and proliferation—Kif11. This enzyme is a molecular motor of the
mitotic kinesin family, and is needed both for formation of the mitotic spindle during mitosis as well as for
microtubule-based cell motility. Furthermore, it can be inhibited with clinically available drugs that we have
shown significantly prolong survival in mouse models of glioblastoma. In this application, we will examine how
to optimize the delivery of these drugs to the central nervous system and to identify and overcome the
mechanisms tumor cells use to develop resistance to them. Results from these translational studies will be
vital to our ongoing efforts at developing Kif11 inhibitors as new and effective therapies for the treatment of
glioblastoma.
项目描述
胶质母细胞瘤以不可控制的方式增殖并在正常脑内广泛分散的能力
定义恶性表型并使这种疾病一致致命。我们发现了一种酶
对胶质母细胞瘤的侵袭和增殖至关重要-Kif 11。这种酶是一种分子马达,
有丝分裂驱动蛋白家族,并且在有丝分裂期间形成有丝分裂纺锤体以及
基于微管的细胞运动。此外,它可以被抑制与临床可用的药物,我们有
在胶质母细胞瘤小鼠模型中显示出显著延长的存活。在这个应用程序中,我们将研究如何
以优化这些药物向中枢神经系统的递送,并识别和克服
肿瘤细胞用来产生耐药性的机制。这些转化研究的结果将
这对于我们正在努力开发Kif 11抑制剂作为治疗以下疾病的新的有效疗法至关重要:
胶质母细胞瘤
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter Canoll其他文献
Peter Canoll的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter Canoll', 18)}}的其他基金
Mathematical Oncology Systems Analysis Imaging Center (MOSAIC)
数学肿瘤学系统分析成像中心 (MOSAIC)
- 批准号:
10729420 - 财政年份:2023
- 资助金额:
$ 56.06万 - 项目类别:
Single Nucleus Transcriptional Profiling of Intractable Focal Epilepsy
难治性局灶性癫痫的单核转录谱
- 批准号:
10373149 - 财政年份:2022
- 资助金额:
$ 56.06万 - 项目类别:
Single Nucleus Transcriptional Profiling of Intractable Focal Epilepsy
难治性局灶性癫痫的单核转录谱
- 批准号:
10544524 - 财政年份:2022
- 资助金额:
$ 56.06万 - 项目类别:
Image-based models of tumor-immune dynamics in glioblastoma
胶质母细胞瘤肿瘤免疫动力学的基于图像的模型
- 批准号:
10361416 - 财政年份:2021
- 资助金额:
$ 56.06万 - 项目类别:
Langworthy Diversity Supplement: Image-based models of tumor-immune dynamics in glioblastoma
Langworthy Diversity Supplement:基于图像的胶质母细胞瘤肿瘤免疫动力学模型
- 批准号:
10381307 - 财政年份:2021
- 资助金额:
$ 56.06万 - 项目类别:
Diversity Supplement Ifediora: Image-based models of tumor-immune dynamics in glioblastoma
多样性补充 Ifediora:胶质母细胞瘤肿瘤免疫动力学的基于图像的模型
- 批准号:
10746512 - 财政年份:2021
- 资助金额:
$ 56.06万 - 项目类别:
Image-based models of tumor-immune dynamics in glioblastoma
胶质母细胞瘤肿瘤免疫动力学的基于图像的模型
- 批准号:
10737767 - 财政年份:2021
- 资助金额:
$ 56.06万 - 项目类别:
Image-based models of tumor-immune dynamics in glioblastoma
胶质母细胞瘤肿瘤免疫动力学的基于图像的模型
- 批准号:
10580715 - 财政年份:2021
- 资助金额:
$ 56.06万 - 项目类别:
Image-based models of tumor-immune dynamics in glioblastoma
胶质母细胞瘤肿瘤免疫动力学的基于图像的模型
- 批准号:
10524208 - 财政年份:2021
- 资助金额:
$ 56.06万 - 项目类别: